fbpx JLABS Video Resources | JLABS

JLABS Video Resources

Cuomo Sets Sights On Middle Class, Sciences During State Of State Speech

Submitted by admin on Mon, 01/09/2017 - 18:15
A cornerstone of Cuomo’s plan is a $650 million initiative to develop the life sciences industry across the state, with a $17 million capital investment for the development of a new life sciences hub in New York City, dubbed JLABS @ NYC. The 30,000 square-foot incubator is a collaboration between Johnson & Johnson and the New York Genome Center and will host up to 30 life science startups within the facility.

Cuomo proposes spending $650 million on the life-sciences sector in New York

Submitted by admin on Mon, 01/09/2017 - 16:45
The state will provide $17 million in capital funding to launch JLABS @ NYC, which Cuomo’s office describes as a “collaboration” between Johnson & Johnson Innovation and the New York Genome Center to build a 30,000-square-foot incubator with capacity for up to 30 life-science startups.

J&J, fueled by $17M in state cash, starts work on 30-startup JLABS incubator to address NYC lab shortage

Submitted by admin on Tue, 01/10/2017 - 03:30
New York has long looked at biotech hubs such as Boston and the Bay Area and questioned why, when it has such riches in terms of academic institutes and NIH funding, it has failed to build a startup scene of note. A lack of affordable lab space in a city where land is at a premium typically features high on the list of reasons. That is why New York Governor Andrew Cuomo has allocated $17 million to bring J&J and its fast-growing JLABS initiative to the city.

JLABS @ NYC Will House Life Science Startups

Submitted by admin on Tue, 01/10/2017 - 16:30
The 30,000-square foot facility — a collaborative effort by Johnson & Johnson Innovation, New York State and New York Genome Center — will have capacity for up to 30 life science startups focused on biotech, pharmaceutical, medical devices and consumer health.

Johnson & Johnson Innovation Plans Research Center in New York City

Submitted by admin on Mon, 01/09/2017 - 16:45
JLABS, in addition to offering emerging life science companies modular lab units, office space, shared core laboratory equipment and business facilities, will link the entrepreneurs of New York with the full breadth of Johnson & Johnson Innovation, including opportunities for funding, third-party services, educational events and R&D experts from medical technology, consumer healthcare product and Janssen pharmaceutical teams.

Johnson & Johnson (JNJ) Gets $17 Million From NYC For JLABS Incubator

Submitted by admin on Wed, 01/11/2017 - 14:15
Johnson & Johnson is embarking on a new project. New York Gov. Andrew Cuomo has confirmed that J&J will receive funding worth $17 million from the state to open a 30,000-square-foot biotech JLABS incubator. The project, which is due to open in the New York Genome Center in 2018 will come in handy for startups who are currently facing space challenges.

Johnson & Johnson taps Lowell's M2D2 for training site

Submitted by admin on Sun, 12/04/2016 - 08:30
Johnson & Johnson's sponsorship also includes a medical-device start-up competition called the Quickfire Challenge in which the winner will get lab space in M2D2 for free for one year, with access to Johnson & Johnson mentoring. The winner will be announced in May, when the JLABS is officially launched.

Baltimore startup wins $500,000 grant from Johnson & Johnson

Submitted by admin on Thu, 11/17/2016 - 07:15
Baltimore-based Glyscend Inc. was awarded one of three $500,000 research grants from Johnson & Johnson Innovation LLC and its research arm Janssen as part of the health care giant's World Without Disease QuickFire Challenge.

J&J awards $1.5 million to QuickFire Challenge winners

Submitted by admin on Tue, 11/15/2016 - 14:00
The three winners were chosen from a pool of 470 global applicants, spread throughout 40 countries. Along with the funding boost, the successful programs will gain access to JLABS incubator space in a location of their choice.

How incubators are accelerating early drug development

Submitted by admin on Mon, 11/07/2016 - 16:45
Part of Johnson & Johnson's Innovation Centers, JLABS is celebrating its fifth anniversary in January. The program started with some extra space at the J&J Innovation facility in San Diego that the company rented out to a smaller biotech, but has now expanded to six locations across North America and includes more than 140 companies.

Key people to know in early drug development: Melinda Richter, Head, JLABS

Submitted by admin on Mon, 11/07/2016 - 16:45
JLABS is probably the best-known incubator in the biopharma industry. Since its inception in 2012, JLABS has expanded to six locations across North America and currently hosts 144 companies. Melinda Richter, head of JLABS, has been at the center of that growth.